Donskov, Frede, Niels Viggo Jensen, and Torben Smidt-Hansen. “A Randomized Phase II Trial of Interleukin-2 and Interferon-α Plus Bevacizumab Versus Interleukin-2 and Interferon-α in Metastatic Renal-Cell Carcinoma (mRCC): Results from the Danish Renal Cancer Group (DaRenCa) Study-1”. Acta Oncologica 57, no. 5 (May 4, 2018): 589–594. Accessed June 29, 2026. https://medicaljournalssweden.se/actaoncologica/article/view/24718.